MedTrace Logo

Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma

NCT02384434 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-06-27

Study results available
· View outcomes & findings →

Summary

This study will assess the efficacy of LLLT to mitigate and ameliorate the acneiform-rash, radiation dermatitis, and pain, while assessing its impact on patient reported quality of life.

Conditions

  • Radiation Dermatitis

Interventions

DEVICE

THOR Laser System for Low Level Laser Therapy (LLLT)

Non-invasive, a cold laser output treatment.

Sponsors & Collaborators

  • Heath Skinner

    lead OTHER

Principal Investigators

  • Heath Skinner, MD · UPMC Hillman Cancer Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-27
Primary Completion
2020-10-13
Completion
2020-10-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02384434 on ClinicalTrials.gov